This process is known as gene cloning (Council for Responsible Genetics).
The extracted gene may be slightly modified before insertion into the target organism. The transgene is inserted into the cells of the recipient organism, a process known as transformation.
Cloning is considered a third method of HGE (Annas, Andrews, & Isasi, 2002).
The US Department of Energy genomics divides cloning into three: therapeutic cloning, reproductive cloning, and DNA cloning or recombinant DNA technology (Bledrzycki, 2005).
The rest of the world has no laws for or against gene therapy.
For example, in India, the Indian Council of Medical Research (ICMR) considers gene therapy a matter of ethical considerations, as it involves humans as ‘subjects’ in the research process.
One major setback of using HGE, is that the after-effects or consequences are not yet known.
Scientists in the effort to cure one disease can inadvertently facilitate another disease to flourish (Haga & Willard, 2006).
DNA cloning involves transferring a DNA part from an organism to a genetic element with self-replicating abilities to enable the DNA to undergo self-replication in a foreign host cell (Annas et al., 2002). It has the capacity to eradicate the development of disease processes.
The gene mutations can arrest diseases like cystic fibrosis, cardiac diseases, and Alzheimer’s disease.